Sulforaphane sensitizes human breast cancer cells to paclitaxel‑induced apoptosis by downregulating the NF‑κB signaling pathway

  • Authors:
    • Seung‑Hyun Kim
    • Hyun‑Jung Park
    • Dong‑Oh Moon
  • View Affiliations

  • Published online on: March 29, 2017     https://doi.org/10.3892/ol.2017.5950
  • Pages: 4427-4432
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sulforaphane (SFN), an isothiocyanate present in cruciferous vegetables, has been demonstrated to inhibit the growth of various types of cancer cell. The aim of the present study was to investigate whether SFN sensitizes breast cancer cells to paclitaxel‑induced apoptosis and to identify the signal pathway through which SFN mediates apoptosis. Combined treatment of breast cancer cells with SFN and paclitaxel resulted in increased activation of apoptotic signaling pathway members, including caspase‑3, ‑8 and ‑9, and cytochrome c, compared with treatment with SFN or paclitaxel alone. In addition, treatment with SFN and paclitaxel resulted in downregulation of the nuclear factor kappa B signaling pathway, and reduced protein expression of apoptosis regulator Bcl‑2 and phosphorylated AKT serine/threonine kinase. Furthermore, SFN‑paclitaxel‑induced apoptosis was inhibited by overexpression of Bcl‑2. The results of the present study suggest that combined treatment with SFN and paclitaxel is a novel therapeutic strategy for the treatment of breast cancer.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim SH, Park HJ and Moon DO: Sulforaphane sensitizes human breast cancer cells to paclitaxel‑induced apoptosis by downregulating the NF‑κB signaling pathway. Oncol Lett 13: 4427-4432, 2017
APA
Kim, S., Park, H., & Moon, D. (2017). Sulforaphane sensitizes human breast cancer cells to paclitaxel‑induced apoptosis by downregulating the NF‑κB signaling pathway. Oncology Letters, 13, 4427-4432. https://doi.org/10.3892/ol.2017.5950
MLA
Kim, S., Park, H., Moon, D."Sulforaphane sensitizes human breast cancer cells to paclitaxel‑induced apoptosis by downregulating the NF‑κB signaling pathway". Oncology Letters 13.6 (2017): 4427-4432.
Chicago
Kim, S., Park, H., Moon, D."Sulforaphane sensitizes human breast cancer cells to paclitaxel‑induced apoptosis by downregulating the NF‑κB signaling pathway". Oncology Letters 13, no. 6 (2017): 4427-4432. https://doi.org/10.3892/ol.2017.5950